David Sidransky - 18 Mar 2026 Form 3/A - Amendment Insider Report for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)

Reporting relationship: Director
Issuer ticker: AAPG
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3/A - Amendment
Accepted by SEC: 23 Mar 2026, 19:14:28 UTC
Original report date: 19 Mar 2026
Prior SEC filing: 07 Nov 2025
Source filing: View source filing
Reporting owner signature: /David Sidransky/

Key filing fact

David Sidransky filed Form 3/A - Amendment for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) on 23 Mar 2026.

Key facts

This page summarizes David Sidransky's Form 3/A - Amendment filing for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 23 Mar 2026, 19:14.

Change

Previous filing in this sequence was filed on 07 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001277161 Primary reporting owner

SIDRANSKY DAVID

Relationship: Director
Address: 700 KING FARM BLVD, STE 510, ROCKVILLE
Signature: /David Sidransky/
Signature date: 23 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AAPG holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,641
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AAPG holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 18,850
Exercise price: $8.14
Footnotes: F2, F3, F5

AAPG holding Derivative

Restricted share units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 28,850
Exercise price: $0.000000
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The number of Ordinary Shares were inadvertently not reported in the original submission.

Footnote F2

The stock options vest in twelve (12) tranches equally on the 26th of the month starting November 26, 2025.

Footnote F3

The exercise price for the stock options is in HKD, and the exercise price included in the table represents conversion to USD based on the exchange rate on the date of grant.

Footnote F4

Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029.

Footnote F5

The number of Share Options and/or vesting were inadvertently incorrectly reported in the original submission.